U.S. President Donald Trump expressed confidence on Wednesday that China will soon impose the death penalty for fentanyl manufacturing and trafficking, signaling renewed optimism for a bilateral crackdown on the opioid crisis. Speaking ahead of signing the HALT Fentanyl Act, Trump emphasized collaboration with Beijing to halt the flow of synthetic opioids, which have claimed over 450,000 American lives in the past decade.
Fentanyl, a powerful synthetic opioid, remains a top cause of overdose deaths in the U.S., and Washington continues to pressure Beijing to tighten control over precursor chemicals exported from China. Trump’s remarks follow a series of recent moves aimed at reining in the deadly drug trade, including the February imposition of 20% tariffs on Chinese goods linked to fentanyl-related issues.
“I think China’s going to go from doing nothing to issuing the death penalty for those producing fentanyl and sending it here,” Trump told reporters. He added that talks with Chinese leader Xi Jinping were progressing and that Beijing was taking “big steps” in response.
In recent weeks, China has added two more fentanyl precursors—4-piperidone and 1-boc-4-piperidone—to its list of controlled substances. Authorities have also ramped up enforcement, seizing over 2 tons of drugs and arresting 262 individuals for trafficking. Over 1,300 prosecutions and 700 arrests for drug-related money laundering have been reported this year, showing a 2.1% increase from last year.
China, however, has pushed back on U.S. demands to publicize its efforts prominently and has accused Washington of politicizing the fentanyl issue. Still, Trump’s latest remarks suggest a possible breakthrough in cooperation as both nations grapple with rising overdose deaths and escalating tensions.


Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
Japan Election 2026: Sanae Takaichi Poised for Landslide Win Despite Record Snowfall
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Illinois Joins WHO Global Outbreak Network After U.S. Exit, Following California’s Lead
Federal Judge Restores Funding for Gateway Rail Tunnel Project
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
New York Legalizes Medical Aid in Dying for Terminally Ill Patients 



